Olfactory and gustatory disorders in COVID-19

Loss of olfaction is one of the symptoms most commonly reported by patients with coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high, recent studies have shown that up to 7% of patients remain anosmic for more than 12 months after the onset of infection, leaving milli...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimek, Ludger, Hagemann, Jan, Döge, Julia, Freudelsperger, Laura, Cuevas, Mandy, Klimek, Felix, Hummel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208356/
https://www.ncbi.nlm.nih.gov/pubmed/35755859
http://dx.doi.org/10.1007/s40629-022-00216-7
_version_ 1784729723395375104
author Klimek, Ludger
Hagemann, Jan
Döge, Julia
Freudelsperger, Laura
Cuevas, Mandy
Klimek, Felix
Hummel, Thomas
author_facet Klimek, Ludger
Hagemann, Jan
Döge, Julia
Freudelsperger, Laura
Cuevas, Mandy
Klimek, Felix
Hummel, Thomas
author_sort Klimek, Ludger
collection PubMed
description Loss of olfaction is one of the symptoms most commonly reported by patients with coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high, recent studies have shown that up to 7% of patients remain anosmic for more than 12 months after the onset of infection, leaving millions of people worldwide suffering from severe olfactory impairment. Olfactory training remains the first recommended treatment. With the continued lack of approved drug treatments, new therapeutic options are being explored. This article reviews the current state of science on COVID-19-related olfactory disorders, focusing on epidemiology, pathophysiology, cure rates, currently available treatment options, and research on new treatments.
format Online
Article
Text
id pubmed-9208356
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-92083562022-06-21 Olfactory and gustatory disorders in COVID-19 Klimek, Ludger Hagemann, Jan Döge, Julia Freudelsperger, Laura Cuevas, Mandy Klimek, Felix Hummel, Thomas Allergo J Int Review Loss of olfaction is one of the symptoms most commonly reported by patients with coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high, recent studies have shown that up to 7% of patients remain anosmic for more than 12 months after the onset of infection, leaving millions of people worldwide suffering from severe olfactory impairment. Olfactory training remains the first recommended treatment. With the continued lack of approved drug treatments, new therapeutic options are being explored. This article reviews the current state of science on COVID-19-related olfactory disorders, focusing on epidemiology, pathophysiology, cure rates, currently available treatment options, and research on new treatments. Springer Medizin 2022-06-20 2022 /pmc/articles/PMC9208356/ /pubmed/35755859 http://dx.doi.org/10.1007/s40629-022-00216-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Klimek, Ludger
Hagemann, Jan
Döge, Julia
Freudelsperger, Laura
Cuevas, Mandy
Klimek, Felix
Hummel, Thomas
Olfactory and gustatory disorders in COVID-19
title Olfactory and gustatory disorders in COVID-19
title_full Olfactory and gustatory disorders in COVID-19
title_fullStr Olfactory and gustatory disorders in COVID-19
title_full_unstemmed Olfactory and gustatory disorders in COVID-19
title_short Olfactory and gustatory disorders in COVID-19
title_sort olfactory and gustatory disorders in covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208356/
https://www.ncbi.nlm.nih.gov/pubmed/35755859
http://dx.doi.org/10.1007/s40629-022-00216-7
work_keys_str_mv AT klimekludger olfactoryandgustatorydisordersincovid19
AT hagemannjan olfactoryandgustatorydisordersincovid19
AT dogejulia olfactoryandgustatorydisordersincovid19
AT freudelspergerlaura olfactoryandgustatorydisordersincovid19
AT cuevasmandy olfactoryandgustatorydisordersincovid19
AT klimekfelix olfactoryandgustatorydisordersincovid19
AT hummelthomas olfactoryandgustatorydisordersincovid19

Ejemplares similares